We are live on ! Find out more
EVH icon

Evolent Health
EVH

174 hedge funds and large institutions have $585M invested in Evolent Health in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 80 increasing their positions, 45 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

361% more call options, than puts

Call options by funds: $12.1M | Put options by funds: $2.63M

78% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 45

2.92% more ownership

Funds ownership: 97.14% → 100.06% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less capital invested

Capital invested by funds: $611M → $585M (-$26M)

5% less funds holding

Funds holding: 183 → 174 (-9)

26% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 27

Holders
174
Holders Change
-9
Holders Change %
-4.92%
% of All Funds
3.82%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
20
Increased
80
Reduced
45
Closed
27
Calls
$12.1M
Puts
$2.63M
Net Calls
+$9.49M
Net Calls Change
+$5.29M

Top Buyers

Rank Fund Capital Flow
1
SAM
Silvercrest Asset Management
New York
+$14.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$11.6M
3
JP Morgan Chase
JP Morgan Chase
New York
+$10.7M
4
BlackRock
BlackRock
New York
+$10.1M
5
CTA
Carillon Tower Advisers
Florida
+$8.38M

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$8.56M
2
Citigroup
Citigroup
New York
-$8.08M
3
WRF
Waddell & Reed Financial
Kansas
-$8.03M
4
Stifel Financial
Stifel Financial
Missouri
-$6.06M
5
LOAMU
Lombard Odier Asset Management (USA)
New York
-$5.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCS
26
Levin Capital Strategies
New York
$6.19M +$1.88M +261,835 +44%
Millennium Management
27
Millennium Management
New York
$6.13M +$5.13M +714,210 +513%
Handelsbanken Fonder
28
Handelsbanken Fonder
Sweden
$5.39M -$359K -50,000 -6%
VCM
29
Voce Capital Management
California
$5.04M +$1.94M +270,996 +63%
Prudential Financial
30
Prudential Financial
New Jersey
$4.82M -$1M -139,955 -17%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$4.64M -$122K -17,012 -3%
RPA
32
Rock Point Advisors
Vermont
$4.5M +$1.37M +191,230 +44%
Point72 Asset Management
33
Point72 Asset Management
Connecticut
$3.76M +$3.76M +523,524 New
Two Sigma Advisers
34
Two Sigma Advisers
New York
$3.62M +$121K +16,900 +3%
American Century Companies
35
American Century Companies
Missouri
$3.51M -$1.5M -209,644 -30%
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$3.45M +$2.56M +356,527 +289%
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$3.37M – – –
GC
38
Guggenheim Capital
Illinois
$3.35M +$1.32M +184,294 +65%
DIM
39
DC Investments Management
Virginia
$3.35M +$2.04M +284,119 +156%
Charles Schwab
40
Charles Schwab
California
$3.23M +$154K +21,503 +5%
Marshall Wace
41
Marshall Wace
United Kingdom
$3.02M -$8.56M -1,193,417 -74%
WPIC
42
White Pine Investment Company
Michigan
$2.98M +$1.74M +242,827 +142%
Deutsche Bank
43
Deutsche Bank
Germany
$2.94M -$4.37M -608,833 -60%
N
44
Nuveen
North Carolina
$2.87M +$122K +16,994 +4%
IAS
45
IMA Advisory Services
Colorado
$2.72M +$921K +128,367 +51%
Wells Fargo
46
Wells Fargo
California
$2.62M +$657K +91,518 +34%
Two Sigma Investments
47
Two Sigma Investments
New York
$2.57M -$3.24M -450,860 -56%
CM
48
Crestline Management
Texas
$2.41M +$628K +87,500 +35%
Goldman Sachs
49
Goldman Sachs
New York
$2.29M -$4.41M -614,614 -66%
GIM
50
Granahan Investment Management
Massachusetts
$2.2M +$160K +22,347 +8%
1
2
3 4 5

EVH Hedge Fund Activity: Q3 2019 in Review

174 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q3 2019, worth a combined $585M — down 4.3% from $611M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of EVH and 20 opened new positions — a net loss of 7 holders — while 45 trimmed existing stakes and 80 added.

The largest buyer was Silvercrest Asset Management, opening a new position worth an estimated $14.6M. The largest seller was Marshall Wace, cutting an estimated $8.56M.

  • 174 institutional investors held Evolent Health (EVH) as of Q3 2019, down from 183 in Q2 2019.
  • Funds reported $585M of Evolent Health stock for Q3 2019, down 4.3% quarter-over-quarter.
  • 20 funds opened new Evolent Health positions in Q3 2019 and 27 closed out, a net change of -7 holders.
  • The largest Evolent Health buyer in Q3 2019 was Silvercrest Asset Management, an estimated $14.6M added.
  • The largest Evolent Health seller in Q3 2019 was Marshall Wace, an estimated $8.56M sold.

Based on aggregated 13F filings for Q3 2019.